Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)

Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021

additional investment to upgrade office building’s facilities. - Administration expenses increased due to additional headcount required for the succession plan. Extraordinary items included 15.2 million baht

first major period of generational succession. • Succession versus professionalization. - Surveys suggest preference amongst Asian family-firms for succession but growing recognition of need for

) EY 4 EY EY AQI 3 EY (3:1) 6:1) EY senior manager manager EY staff turnover 27.33%) (20.31%) EY EY career path) succession plan) EY 3.5 (Engagement Performance) EY engagement partner ) EY 2 engagement

SERVICES PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking JSP JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56-2 Ranking JUBILE JUBILEE

LIMITED Please enter search criteria Search Company ACE: ABSOLUTE CLEAN ENERGY PUBLIC COMPANY LIMITED JSP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED PEACE: PEACE & LIVING PUBLIC

firms in Asia include, in particular, leadership succession and corruption or family conflicts. Some research on family-controlled firms was cited illustrating the significant shareholder value that

work constructively with the company to remove the impediment. A recent example of this type of engagement had to do with the mix of skill sets on a pharmaceutical company’s board. Several years before